María del Pilar de la Huerta Martínez
Finanzdirektor/CFO bei BIOFRONTERA AG
Ursprung des Netzwerks ersten Grades von María del Pilar de la Huerta Martínez
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
22
| Public Company | Financial Conglomerates | 22 |
| Public Company | Pharmaceuticals: Major | 7 | |
Vaxdyn SL
 Vaxdyn SL BiotechnologyHealth Technology Vaxdyn SL discovers and develops antigens. Its products include pipeline, clinical need and R&D programs. The company was founded by Jeronimo Pachon, Pilar Perez-Romero and Michael J. McConnell in 2011 and is headquartered in Seville, Spain.
6
| Holding Company | Biotechnology | 6 |
| Public Company | Biotechnology | 5 | |
Antibióticos de León SLU
 Antibióticos de León SLU Pharmaceuticals: MajorHealth Technology Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von María del Pilar de la Huerta Martínez
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Expedeon Ltd.
 Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
Expedeon Holdings Ltd.
 Expedeon Holdings Ltd. BiotechnologyHealth Technology Expedeon Holdings Ltd. develops, manufactures, and commercializes proteomics reagents and tools. The company was founded on January 7, 2009 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chairman | |
Delphi Unternehmensberatung AG
 Delphi Unternehmensberatung AG Financial ConglomeratesFinance Delphi Unternehmensberatung AG provides investment services. The company is based in Heidelberg, Germany. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal Chairman | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Universidad Autónoma de Madrid | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Genetrix SL
 Genetrix SL BiotechnologyHealth Technology Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain. | Biotechnology | Founder Director/Board Member Director/Board Member | |
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
SATLANTIS Microsats SA
 SATLANTIS Microsats SA Major TelecommunicationsCommunications SATLANTIS Microsats SL develops the infrastructure for manufacture, integration, launch, and operations of standardized microsatellites. Its Integrated Standard Imager for Earth Observation Microsatellites is an optical imaging product for scientific and commercial applications. The company was founded by Llorente Rafael Guzman in 2013 and is headquartered in Getxo, Spain. | Major Telecommunications | Director/Board Member Chairman | |
STRAWTEC Group AG
 STRAWTEC Group AG Engineering & ConstructionIndustrial Services STRAWTEC Group AG provides engineering and construction services. The firm offers installation, finishing and housing services. The company is headquartered in Heidelberg, Germany. | Engineering & Construction | Corporate Officer/Principal Chairman | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
4basebio UK Ltd.
 4basebio UK Ltd. Wholesale DistributorsDistribution Services 4basebio Ltd. engages in the genomics and DNA manufacturing business. The company was founded on November 5, 2019 and is headquartered in Cambridge, the United Kingdom. | Wholesale Distributors | Director/Board Member Director/Board Member | |
| HEIDELBERGER BETEILIGUNGSHOLDING AG | Financial Conglomerates | Corporate Officer/Principal Director/Board Member | |
Heqet Therapeutics SRL
 Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Heqet Therapeutics SRL is an Italian biotechnology company that specializes in cardiac regenerative medicine. The company is based in Turin, Italy. The company was founded by Mauro Giacca. Marta Antonucci has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chairman | |
| Febit, Inc. | Director/Board Member Chairman | ||
| Fachhochschule Ludwigshafen am Rhein | College/University | Corporate Officer/Principal Graduate Degree | |
| SPARTA AG | Investment Managers | Chairman Director/Board Member | |
| University of Freiburg | College/University | Doctorate Degree Graduate Degree | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| DEUTSCHE BALATON AG | Investment Banks/Brokers | Corporate Officer/Principal Chairman | |
| EPIGENOMICS AG | Medical Specialties | Director/Board Member Chairman | |
| BIOTECHNOLOGY ASSETS, S.A. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| Alpha Cleantec AG | Corporate Officer/Principal Chairman | ||
| MARNA BETEILIGUNGEN AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
SRH Kliniken GmbH
 SRH Kliniken GmbH Hospital/Nursing ManagementHealth Services Part of SRH Holding (SdbR), SRH Kliniken GmbH is a healthcare company that operates multiple clinics across Germany, including locations in Gera, Karlsbad-Langensteinbach, Bad Wimpfen, Neresheim, Oberndorf a.N., Bad Kösen, and others. The company is based in Heidelberg, Germany. The company provides medical services and treatments to patients in these regions. The CEO of the company is Werner Stalla. | Hospital/Nursing Management | Chairman Director/Board Member | |
| SYMRISE AG | Chemicals: Specialty | Director/Board Member | |
European Regions Airline Association Ltd.
 European Regions Airline Association Ltd. Miscellaneous Commercial ServicesCommercial Services European Regions Airline Association Ltd. operates as an association that promotes aviation. The non-profit company is based in Lightwater, UK. | Miscellaneous Commercial Services | Director/Board Member | |
| I2i Capital Ltd. | Director/Board Member | ||
Nestlé USA, Inc.
 Nestlé USA, Inc. Agricultural Commodities/MillingProcess Industries Nestle USA, Inc. produces dairy and bakery products. Its products include chocolate and confectionaries, beverages, ice cream, juices, milk products, pet food, prepared foods, and sports nutrition. The company is headquartered in Arlington, VA. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
BioMedPartners AG
 BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Chairman | |
| University of Lausanne | College/University | Corporate Officer/Principal | |
| Wuerzburg Schweinfurt University of Applied Sciences | College/University | Doctorate Degree | |
| BIOFRONTERA INC. | Pharmaceuticals: Major | Director/Board Member | |
| Natures Remedies Ltd. | Chief Executive Officer | ||
Prospero Biotech Ltd.
 Prospero Biotech Ltd. Investment ManagersFinance Prospero Biotech Ltd. (Prospero) is an independent UK private equity firm which specializes in providing formation management to early-stage bioventures. Based in London, Prosepro seeks to work with academic institutions who wish to commercialize their technology base, biotech ventures that may want to access new markets or that want to spin-off or sell a technology that is no longer core to their interests or corporations aiming to develop high potential new ventures in the medical or biotech sectors. | Investment Managers | Private Equity Investor | |
| The University of Hull | College/University | Doctorate Degree | |
| Cambridge Cell Networks Ltd. | Director/Board Member | ||
NeoPhore Ltd.
 NeoPhore Ltd. Miscellaneous Commercial ServicesCommercial Services NeoPhore Ltd. engages in discovery and development of small molecules inhibitors to treat cancer. The company is headquartered in Kings Cross, London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
| Deutschland | 27 |
| Vereinigtes Königreich | 12 |
| Vereinigte Staaten | 6 |
| Spanien | 5 |
| Schweiz | 4 |
Sektoral
| Health Technology | 18 |
| Finance | 9 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Health Services | 3 |
Operativ
| Director/Board Member | 227 |
| Chairman | 85 |
| Corporate Officer/Principal | 51 |
| Chief Executive Officer | 45 |
| Founder | 27 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- María del Pilar de la Huerta Martínez
- Unternehmensverbindungen
